UK markets closed

Dechra Pharmaceuticals plc (DPH.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
5,170.00-55.00 (-1.05%)
At close: 4:35PM BST
Currency in GBp

Valuation measures

Market cap (intra-day) 55.59B
Enterprise value 35.79B
Trailing P/E 101.37
Forward P/E 141.54
PEG ratio (5-yr expected) 14.84
Price/sales (ttm)9.20
Price/book (mrq)883.91
Enterprise value/revenue 39.53
Enterprise value/EBITDA 747.11

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 361.16%
S&P500 52-week change 332.94%
52-week high 35,525.00
52-week low 32,443.80
50-day moving average 35,134.00
200-day moving average 34,368.20

Share statistics

Avg vol (3-month) 3277.82k
Avg vol (10-day) 3534.83k
Shares outstanding 5108.22M
Implied shares outstanding 6N/A
Float 8107.75M
% held by insiders 11.59%
% held by institutions 170.59%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.41
Forward annual dividend yield 40.78%
Trailing annual dividend rate 30.41
Trailing annual dividend yield 30.01%
5-year average dividend yield 41.03
Payout ratio 468.80%
Dividend date 3N/A
Ex-dividend date 428 Oct 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Jun 2021
Most-recent quarter (mrq)30 Jun 2021


Profit margin 9.13%
Operating margin (ttm)14.31%

Management effectiveness

Return on assets (ttm)4.44%
Return on equity (ttm)8.74%

Income statement

Revenue (ttm)608M
Revenue per share (ttm)5.62
Quarterly revenue growth (yoy)15.60%
Gross profit (ttm)345.9M
Net income avi to common (ttm)55.5M
Diluted EPS (ttm)51.00
Quarterly earnings growth (yoy)55.60%

Balance sheet

Total cash (mrq)118.4M
Total cash per share (mrq)1.09
Total debt (mrq)318.6M
Total debt/equity (mrq)50.34
Current ratio (mrq)2.52
Book value per share (mrq)5.85

Cash flow statement

Operating cash flow (ttm)89.1M
Levered free cash flow (ttm)-23.82M